Your browser is no longer supported. Please, upgrade your browser.
ViewRay, Inc.
Index- P/E- EPS (ttm)-0.69 Insider Own11.50% Shs Outstand164.25M Perf Week-7.86%
Market Cap820.22M Forward P/E- EPS next Y-0.64 Insider Trans-27.56% Shs Float123.23M Perf Month-11.61%
Income-109.10M PEG- EPS next Q-0.16 Inst Own80.00% Short Float6.00% Perf Quarter-23.32%
Sales68.20M P/S12.03 EPS this Y38.10% Inst Trans-8.04% Short Ratio5.36 Perf Half Y-29.91%
Book/sh0.72 P/B6.35 EPS next Y7.50% ROA-40.30% Target Price8.57 Perf Year-11.09%
Cash/sh0.84 P/C5.47 EPS next 5Y10.00% ROE-79.10% 52W Range3.79 - 8.25 Perf YTD-17.06%
Dividend- P/FCF- EPS past 5Y9.20% ROI-56.60% 52W High-44.61% Beta0.81
Dividend %- Quick Ratio3.00 Sales past 5Y40.60% Gross Margin1.00% 52W Low20.74% ATR0.31
Employees236 Current Ratio3.70 Sales Q/Q90.10% Oper. Margin- RSI (14)35.35 Volatility5.86% 5.59%
OptionableYes Debt/Eq0.00 EPS Q/Q19.00% Profit Margin- Rel Volume0.56 Prev Close4.77
ShortableYes LT Debt/Eq0.49 EarningsNov 04 AMC Payout- Avg Volume1.38M Price4.57
Recom1.70 SMA20-12.73% SMA50-18.07% SMA200-22.31% Volume778,202 Change-4.19%
Jan-11-22Upgrade B. Riley Securities Neutral → Buy $7
Oct-14-21Resumed B. Riley Securities Neutral $7
Jun-25-21Upgrade Morgan Stanley Underweight → Equal-Weight
May-07-21Upgrade Guggenheim Neutral → Buy $7
Mar-26-21Upgrade BTIG Research Neutral → Buy $7
Oct-28-20Upgrade B. Riley Securities Neutral → Buy $2.75 → $4
Jun-16-20Resumed Cantor Fitzgerald Overweight $3
Apr-28-20Downgrade Guggenheim Buy → Neutral
Mar-27-20Downgrade Morgan Stanley Equal-Weight → Underweight $2
Mar-13-20Downgrade BTIG Research Buy → Neutral
Dec-04-19Downgrade B. Riley FBR Buy → Neutral
Oct-22-19Initiated Oppenheimer Outperform $7
Jun-18-19Initiated Piper Jaffray Overweight $15
Mar-15-19Reiterated B. Riley FBR Buy $13.75 → $12
Dec-11-18Initiated Morgan Stanley Equal-Weight $7
Oct-19-18Initiated Robert W. Baird Outperform
Jul-03-18Initiated Jefferies Buy
Feb-08-18Initiated B. Riley FBR, Inc. Buy $13.50
Jan-05-18Resumed Cantor Fitzgerald Overweight
Jun-30-17Initiated Cantor Fitzgerald Overweight $10
Jan-10-22 08:49AM  
Jan-05-22 10:00AM  
Dec-23-21 04:15PM  
Dec-15-21 06:30AM  
Dec-07-21 06:30AM  
Nov-24-21 09:38AM  
Nov-23-21 11:30AM  
Nov-19-21 04:51PM  
Nov-16-21 10:16PM  
Nov-06-21 02:31AM  
Nov-04-21 06:15PM  
Nov-02-21 05:49PM  
Oct-29-21 08:47AM  
Oct-28-21 03:06PM  
Oct-25-21 06:30AM  
Oct-22-21 06:30AM  
Oct-18-21 05:54PM  
Oct-14-21 08:30AM  
Oct-12-21 02:13PM  
Sep-29-21 01:44PM  
Sep-16-21 04:01PM  
Aug-24-21 06:30AM  
Aug-17-21 06:30AM  
Aug-10-21 10:43AM  
Aug-06-21 12:37PM  
Aug-05-21 10:01PM  
Jul-29-21 03:05PM  
Jul-26-21 11:50AM  
Jul-15-21 08:30AM  
Jul-07-21 06:30AM  
Jun-25-21 08:54AM  
Jun-24-21 06:45PM  
Jun-11-21 04:01PM  
May-26-21 03:46AM  
May-25-21 09:00AM  
May-17-21 04:01PM  
May-10-21 07:25AM  
May-07-21 04:26PM  
May-06-21 06:20PM  
Apr-29-21 05:04PM  
Apr-19-21 04:01PM  
Mar-16-21 08:13AM  
Mar-15-21 09:00AM  
Mar-05-21 04:01PM  
Mar-04-21 10:00PM  
Mar-03-21 10:39AM  
Feb-19-21 04:01PM  
Feb-11-21 04:01PM  
Feb-03-21 06:43PM  
Jan-26-21 06:30AM  
Jan-22-21 06:51PM  
Jan-15-21 08:30AM  
Jan-07-21 05:40PM  
Jan-04-21 10:53PM  
Dec-23-20 08:30AM  
Dec-22-20 06:30AM  
Dec-21-20 06:30AM  
Dec-11-20 10:33AM  
Nov-23-20 08:00AM  
Nov-16-20 03:01AM  
Nov-12-20 06:30AM  
Nov-10-20 06:30AM  
Nov-09-20 12:22PM  
Nov-06-20 08:01PM  
Nov-05-20 08:00PM  
Oct-29-20 12:35PM  
Oct-21-20 06:30AM  
Oct-15-20 08:00AM  
Oct-06-20 08:00PM  
Oct-01-20 08:35AM  
Sep-24-20 06:30AM  
Sep-18-20 10:25AM  
Sep-04-20 08:30AM  
Sep-01-20 06:30AM  
Aug-27-20 06:30AM  
Aug-13-20 06:30AM  
Aug-05-20 06:30AM  
ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stassen Zachary WilliamChief Financial OfficerNov 19Buy5.6017,85799,999465,290Nov 19 11:43 AM
Drake Scott WilliamPresident & CEONov 19Buy5.6089,285499,9963,716,281Nov 19 11:42 AM
Strong Influence Ltd10% OwnerNov 08Sale7.024,000,00028,080,00011,108,222Nov 10 06:09 AM
Fosun International Ltd10% OwnerNov 08Sale7.024,000,00028,080,00011,108,222Nov 10 06:08 AM
Stassen Zachary WilliamChief Financial OfficerAug 24Buy5.3240,000212,800447,433Aug 25 04:05 PM
Strong Influence Ltd10% OwnerJun 08Sale5.974,300,00025,671,00015,108,222Jun 10 07:02 AM
Fosun International Ltd10% OwnerJun 08Sale5.974,300,00025,671,00015,108,222Jun 10 07:02 AM